Crossmark Global Holdings, Inc. Seagen Inc. Transaction History

Crossmark Global Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$191.51 - $216.16 $2,106 - $2,377	11 Added 0.91%	1,217 $261,000
Q2 2023 Jul 31, 2023	SELL	$187.64 - $206.25 $6,004 - $6,600	-32 Reduced 2.58%	1,206 $232,000
Q1 2023 May 12, 2023	BUY	$127.59 - $203.08 $157,956 - $251,413	1,238 New	1,238 $250,000
Q2 2022 Jul 29, 2022	BUY	$108.81 - $179.33 $147,002 - $242,274	1,351 New	1,351 $239,000
Q4 2021 Jan 10, 2022	SELL	$142.57 - $190.86 $412,169 - $551,776	-2,891 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$142.45 - $169.82 $411,822 - $490,949	2,891 New	2,891 $491,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.